ALPHINA THERAPEUTICS

alphina-therapeutics-logo

Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that have NAD Metabolic Deficiencies (NMD) through the development of companion diagnostics. Their goal is to develop best-in-class targeted therapies against the NAD pathway nodes in patients whose cancers exhibit hallmarks of NMD and rapidly translate these into the clinic.

#SimilarOrganizations #People #Financial #More

ALPHINA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2020-01-01

Address:
Westport, Connecticut, United States

Country:
United States

Total Employee:
11+

Status:
Closed

Contact:
(203) 435-2255

Total Funding:
16.85 M USD


Similar Organizations

ajax-therapeutics-logo

Ajax Therapeutics

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

lycia-therapeutics-logo

Lycia Therapeutics

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Current Employees Featured

ranjit-s-bindra_image

Ranjit S. Bindra
Ranjit S. Bindra Co-Founder @ Alphina Therapeutics
Co-Founder
2010-06-01

stanley-choy_image

Stanley Choy
Stanley Choy Chief Financial Officer @ Alphina Therapeutics
Chief Financial Officer
2021-01-01

mitch-raponi_image

Mitch Raponi
Mitch Raponi Chief Scientific Officer @ Alphina Therapeutics
Chief Scientific Officer

Founder


ranjit-s-bindra_image

Ranjit S. Bindra

Investors List

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Pre Seed Round - Alphina Therapeutics

highcape-partners_image

HighCape Partners

HighCape Partners investment in Pre Seed Round - Alphina Therapeutics

More informations about "Alphina Therapeutics"

Alphina Therapeutics - Crunchbase Company Profile

Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that โ€ฆSee details»

Alphina Therapeutics Company Profile 2024: Valuation, โ€ฆ

Alphina Therapeutics General Information Description. Developer of new classes of small molecules intended to target multiple nodes in NAD synthesis pathways. The company offers approaches to identify and characterize altered states โ€ฆSee details»

Team - Alphina Therapeutics

Prior to joining Alphina, he served in key scientific leadership roles at oncology- focused companies for more than 17 years. Dr. Damelin most recently served as Vice President and Head of Biology at Mersana Therapeutics, where he โ€ฆSee details»

Alphina Therapeutics - BioCT

Alphina Therapeutics is a biotechnology company established by a team of world-leading experts in DNA repair and metabolic lethality. Alphina aims to leverage proprietary biomarkers and breakthrough insights for the development of โ€ฆSee details»

Alphina Therapeutics - Funding, Financials, Valuation & Investors

Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Search Crunchbase. ... How much funding has โ€ฆSee details»

Alphina Therapeutics - LinkedIn

Alphina Therapeutics | 1,716 followers on LinkedIn. Targeting Metabolic Defects in Cancer | Alphina Therapeutics is a biotechnology company focused on precision medicine in cancerSee details»

Alphina Therapeutics - Products, Competitors, Financials, โ€ฆ

Alphina Therapeutics aims to leverage proprietary biomarkers and breakthrough insights for the development of Nicotinamide Adenine Dinucleotide (NAD) pathway-targeted oncology โ€ฆSee details»

Alphina Therapeutics - Contacts, Employees, Board Members

Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

Alphina Therapeutics - Raised Funding from 3 investors - Tracxn

Oct 23, 2024 flipando - Montevideo based, raised a funding of $600K in Seed round held on 27 Sep, 2024.; Vedantu - Bengaluru based, raised a funding of $2.3M in Series E round held on โ€ฆSee details»

Alphina Therapeutics Information - RocketReach

Alphina Therapeutics is based in New Haven, Connecticut. Top Alphina Therapeutics Employees Stanley Choy Chief Financial Officer at Alphina Therapeutics Greenwich, CT, US View. 1 โ€ฆSee details»

News - Alphina Therapeutics

Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer; Barbara S. Fox, Ph.D., Named Chair of Alphinaโ€™s Board of Directors Read more » Alphina is โ€ฆSee details»

Alphina Therapeutics - Updates, News, Events, Signals & Triggers

Dec 15, 2020 Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Search Crunchbase. โ€ฆSee details»

Alphina Therapeutics Appoints Nick Galli as CEO

Oct 23, 2024 Barbara S. Fox, Ph.D., named chair of Alphina's board of directors. NEW HAVEN, Conn., Oct. 23, 2024 /PRNewswire/ -- Alphina Therapeutics, a biotechnology company โ€ฆSee details»

Alphina Therapeutics Strengthens Management Team with โ€ฆ

Dec 17, 2024 Alphina Therapeutics Strengthens Management Team with Appointment of Marc Damelin, Ph.D. as Chief Scientific Officer PR Newswire Tue, Dec 17, 2024, 7:00 AM 4 min readSee details»

Alphina Therapeutics Appoints Chief Scientific Officer

Dec 17, 2024 Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of solid tumor indications, has appointed Marc โ€ฆSee details»

Alphina Therapeutics - Crunchbase

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies. Alphina Therapeutics and Ajax Therapeutics โ€ฆSee details»

Top Management Shakeups of 2024: Redefining Pharma, โ€ฆ

Dec 20, 2024 Nick Galli, CEO, Alphina Therapeutics. Nick Galliโ€™s leadership at Alphina Therapeutics is centered on advancing its NAMPT inhibitor program for solid tumor โ€ฆSee details»

Alphina Therapeutics - Tech Stack, Apps, Patents & Trademarks

Organization. Alphina Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit โ€ฆSee details»

Careers - Alphina Therapeutics

Join Alphinaโ€™s Team. At Alphina we believe an open, empowered, and diverse team that works together can tackle any challenge. If you have a passion for improving the lives of patients โ€ฆSee details»

linkstock.net © 2022. All rights reserved